Pfizer has announced its entry into the direct-to-consumer business, a significant shift that mirrors a similar move by Eli Lilly earlier this year. Pfizer's new platform, PfizerForAll, is designed to streamline the process for patients seeking treatments for migraines, respiratory viruses, and vaccines. The initiative is part of Pfizer's broader strategy to enhance patient access to its products by simplifying the often complicated and time-consuming healthcare system.